openPR Logo
Press release

Liquid Biopsy Market Expanding with Demand for Non-Invasive Diagnostics and Precision Oncology Solutions Worldwide, 2025-2032

07-13-2025 10:45 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Liquid Biopsy Market

Liquid Biopsy Market

The liquid biopsy industry is witnessing rapid advancements driven by its minimally invasive nature and potential in cancer diagnostics and personalized medicine. Increasing adoption across oncology, prenatal testing, and infectious diseases is propelling industry momentum. Cutting-edge technologies such as next-generation sequencing (NGS) and digital PCR are enhancing the accuracy and utility of liquid biopsy assays, transforming clinical diagnostics and monitoring. The Global Liquid Biopsy Market size is estimated to be valued at USD 3.84 billion in 2025 and is expected to reach USD 11.62 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.8% from 2025 to 2032, reflecting strong market growth and expanding market opportunities in this sphere.

Get sample copy:https://www.coherentmarketinsights.com/insight/request-sample/1223

➤Actionable Insights

● The production capacity of liquid biopsy kits surged by 22% in 2024, reflecting manufacturing scale-up to meet rising clinical demand.
● Pricing trends indicate an average cost decline of 8% per annum due to technological innovations and economies of scale, improving affordability in end-use segments.
● Export volumes of liquid biopsy reagents increased by 30% between 2023-2024, with Asia-Pacific emerging as a primary export market.
● Utilization across oncology diagnostics accounted for over 65% of market revenue in 2024, supported by expanding use cases in treatment monitoring and early cancer detection.
● Demand-side indicators reveal rapid growth in liquid biopsy adoption for non-oncological applications, including prenatal genetic testing, which grew 18% in 2024.

❖Market Segment and Regional Coverage

○ By Sample Type: Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs), exosomes, microRNAs, and others.
○ By Technology: Next-Generation Sequencing (NGS), Digital PCR, BEAMing, and Others.
○ By Application: Oncology Diagnostics, Prenatal Testing, Infectious Disease Detection, Others.
○ By End-User: Hospitals & Diagnostic Centers, Research Laboratories, Pharmaceutical & Biotechnology Companies, Others.

Regional and Country Analysis:

○ North America: U.S. and Canada
○ Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
○ Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
○ Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
○ Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA.

Get Full Report:https://www.coherentmarketinsights.com/market-insight/liquid-biopsy-market-1223?utm_source=openpr.com&utm_medium=referral&utm

✔Key Players

» Guardant Health
» Roche Diagnostics
» Illumina, Inc.
» Biocept, Inc.
» Bio-Rad Laboratories
» Sysmex Corporation
» QIAGEN N.V.
» F. Hoffmann-La Roche AG
» Thermo Fisher Scientific Inc.
» Adaptive Biotechnologies
» Grail, Inc.
» Exact Sciences Corporation
» ArcherDX, Inc.
» Natera, Inc.
» Singlera Genomics
» Laboratory Corporation of America Holdings

» Guardant Health implemented strategic collaborations with major oncology centers in the U.S. throughout 2024, accelerating clinical adoption and achieving a 15% revenue uplift.
» Roche Diagnostics expanded its portfolio with cutting-edge NGS-based liquid biopsy assays in 2025, which strengthened its footprint in Europe and Asia-Pacific markets.
» Illumina partnered with pharmaceutical companies to co-develop companion diagnostics leveraging liquid biopsy, fostering integrated market growth strategies.

➤Growth Factors

✓ Increasing incidence and early detection initiatives for cancers such as lung, breast, and colorectal play a pivotal role in market growth, with lung cancer liquid biopsy procedures seeing a 25% rise in usage in 2024.
✓ Government and private funding for precision oncology and non-invasive diagnostic tools reached USD 400 million globally in 2024, fueling innovation and commercialization.
✓ Rising awareness of liquid biopsy's potential to guide targeted therapies is expanding demand among healthcare providers, especially in North America and Europe.
✓ The reduction in sequencing costs by nearly 30% since 2023 has removed financial barriers, amplifying market revenue opportunities.

❖Market Trends

⇨ Integration of AI and machine learning into liquid biopsy data analysis is enhancing interpretative accuracy, with startups demonstrating a 35% improvement in diagnostic yield in 2024.
⇨ Increasing adoption of multi-cancer early detection (MCED) tests based on liquid biopsy is reshaping oncology diagnostics, gaining regulatory approvals and clinical traction in 2025.
⇨ Expansion of point-of-care liquid biopsy platforms is facilitating decentralized testing models, especially in Asia Pacific markets.
⇨ Collaborative research projects between biotech firms and academic institutions are accelerating the development of novel biomarkers and assay platforms.

✒Key Takeaways

→ Liquid Biopsy Market segments dominated by Circulating Tumor DNA (ctDNA) reflect high sensitivity and clinical acceptance.
→ Next-Generation Sequencing (NGS) technology drives major market revenue due to its multiplexing capacity.
→ Oncology diagnostics are the largest application segment benefiting from advancements in early cancer detection.
→ North America continues to be a leading region with robust clinical infrastructure and reimbursement frameworks.
→ Asia Pacific exhibits dynamic growth led by China and India's expanding healthcare investments and favorable regulatory pathways.
→ Europe's diversified pharmaceutical base and precision medicine initiatives underpin sustained market development.

Buy Now This Report: https://www.coherentmarketinsights.com/insight/buy-now/1223

❓Frequently Asked Questions

1. Who are the dominant players in the Liquid Biopsy market?
The Liquid Biopsy market is led by prominent companies such as Guardant Health, Roche Diagnostics, Illumina, and Biocept, which leverage innovation and strategic partnerships to expand their market presence.

2. What will be the size of the Liquid Biopsy market in the coming years?
The market size for Liquid Biopsy is projected to grow from USD 3.84 billion in 2025 to USD 11.62 billion by 2032, with a CAGR of 17.8%, reflecting strong market momentum and expanding adoption.

3. Which end-user industry has the largest growth opportunity?
Oncology diagnostics currently offers the largest growth opportunity due to expanding use cases in early cancer detection and treatment monitoring, supported by technological advancements and clinical validation.

4. How will market development trends evolve over the next five years?
Trends indicate greater integration of AI analytics, multi-cancer detection capabilities, and point-of-care liquid biopsy platforms, driving market diversification and increased accessibility.

5. What is the nature of the competitive landscape and challenges in the Liquid Biopsy market?
The competitive landscape is characterized by technological innovation, strategic collaborations, and regulatory approvals; challenges include high development costs and the need for clinical validation across diverse applications.

6. What go-to-market strategies are commonly adopted in the Liquid Biopsy market
Companies frequently adopt strategies including partnerships with oncology centers, co-development of companion diagnostics, expansion of geographic footprint, and pricing optimization to drive market share and business growth.

About Us:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

📌Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
📞U.S.: + 12524771362
📞U.K.: +442039578553
📞AUS: +61-2-4786-0457
📞INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liquid Biopsy Market Expanding with Demand for Non-Invasive Diagnostics and Precision Oncology Solutions Worldwide, 2025-2032 here

News-ID: 4101890 • Views:

More Releases from Coherent Market Insights

Space Ground Station Equipment Market: An Analysis of Size, Shares, Business Growth, and Upcoming Trends Forecast 2025-2032 | EchoStar Corporation, AAC Clyde Space
Space Ground Station Equipment Market: An Analysis of Size, Shares, Business Gro …
Space Ground Station Equipment Market is estimated to be valued at USD 10,826.8 Mn in 2025 and is expected to reach USD 18,833.6 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.23% from 2025 to 2032. The latest research study released by Coherent Market Insights on "Space Ground Station Equipment Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a
Crude Transportation Market 2025 Size, Industry Revenue, Growth Insights, Top Players, Recent Developments, and Forecast till 2032 Major Players :EchoStar Corporation, AAC Clyde Space
Crude Transportation Market 2025 Size, Industry Revenue, Growth Insights, Top Pl …
The Crude Transportation Market size is estimated to be valued at USD 25.65 Bn in 2025 and is expected to reach USD 39.09 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.20% from 2025 to 2032. The latest research study released by Coherent Market Insights on "Crude Transportation Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective
Computer Software Assurance (CSA) Market Revenue Growth 2025, Emerging Technologies, Latest Trends, Development Strategies, Global Size and Share Forecast to 2032 | ExxonMobil Corporation, Royal Dutch Shell
Computer Software Assurance (CSA) Market Revenue Growth 2025, Emerging Technolog …
Computer Software Assurance (CSA) Market is estimated to be valued at USD 10.83 Bn in 2025 and is expected to reach USD 25.48 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 13% from 2025 to 2032 The latest research study released by Coherent Market Insights on "Computer Software Assurance (CSA) Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a
Electric Lunch Box Market Outlook, Trend Analysis, Current Growth, Future Scope and Global Forecast 2025-2032 |Capgemini SE, Hewlett Packard Enterprise (HPE)
Electric Lunch Box Market Outlook, Trend Analysis, Current Growth, Future Scope …
The Electric Lunch Box Market size is estimated to be valued at US$ 775.4 Mn in 2025 and is expected to reach US$ 1,212.9 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. The latest research study released by Coherent Market Insights on "Electric Lunch Box Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a

All 5 Releases


More Releases for Liquid

Vitamins: The Liquid Goldmine in the Booming Liquid Dietary Supplements Market
The liquid dietary supplements market is experiencing a surge in popularity, driven by consumers seeking convenient and effective ways to boost their health and wellness. Among the diverse offerings, the vitamins segment stands out as a high-opportunity area, catering to a wide range of health needs and preferences. Market Dynamics and Growth Drivers Liquid vitamins offer a compelling alternative to traditional pills and capsules, providing faster absorption, easier consumption, and customizable dosages.
Thermoelectric Assemblies Market, By Type (Air to Air, Direct to Air, Liquid to …
The thermoelectric assemblies market is expected to witness market growth at a rate of 8.25% in the forecast period of 2021 to 2028. Data Bridge Market Research report on thermoelectric assemblies market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the application of thermoelectric assemblies in the food and beverage industry
Southeast Asia Liquid Gases Market : Growing with a CAGR of 7.1%, By Type (Liqui …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products
Southeast Asia Liquid Gases Market growing with a CAGR of 7.1%, By Type (Liquid …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products
Southeast Asia liquid gases market growing with a CAGR of 7.1%, Size, Share, Tre …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products
Dual Chamber Prefilled Syringes Market 2021 by Product (Liquid/Powder, Liquid/Li …
The Dual Chamber Prefilled Syringes Market report examines the market size by vital countries/regions, product type, application, historical data, and estimate to forecast. It helps to understand the structure of the Dual Chamber Prefilled Syringes Market by recognizing its different sub-segments. Furthermore, the report focuses on key market players to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few